Stewart Bartlett

Ferronova raises another $6 million to advance image-guided cancer surgery

Adelaide medtech Ferronova has banked another $6 million from returning backers to advance its surgical tracer for cancer, lifting Series A funding to $17.5 million; backer parent UltraGreen.ai floated in Singapore this month.

Also movefm.com.au

Biotech Ferronova boosts Series A capital raise by $6m

Adelaide biotech Ferronova added $6 million to its Series A from prior backers, lifting the round's total to $17.5 million; backer Renew's parent Ultragreen.ai floated in Singapore this month.

Also ferronova.com.au·movefm.com.au·Biotech Dispatch·Startup Daily

‘No tumour will go undetected’: Ferronova lands $11 million for its cancer hunting nanotechnology

Adelaide biotech Ferronova raised $11 million for its cancer-detection nanotechnology, with Renew Pharmaceuticals and a government CRC contributing, following an earlier $4.6 million Series A in 2020.

Also SmartCompany

South Australian biotech startup Ferronova banks $11 million to tackle cancer treatment

Adelaide cancer-focused biotech Ferronova has secured fresh backing: an investor round led by Irish strategic partner Renew Pharmaceuticals plus a federal research grant, to speed clinical trials in stomach and brain cancers.

Also SmartCompany·SmartCompany·SmartCompany·Startup Daily·Business News Australia·Startup Daily

Ferronova secures A$11 million to advance nanotech image-guided cancer therapy

Adelaide biotech Ferronova announced an A$11 million package: an A$8 million round led by Ireland's Renew Pharmaceuticals plus an A$3 million government CRC-P grant, with existing shareholders Uniseed and Artesian also participating.